Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

In the News
In The news

Mentavi Health to Present Adult ADHD Validation Data at National Psychopharmacology Update 2026

Source: EIN Presswire
Mentavi Health will present peer-reviewed validation findings at the 31st Annual National Psychopharmacology Update, highlighting its clinically studied online adult ADHD diagnostic evaluation. The Journal of Clinical Psychiatry–published study demonstrates strong agreement with traditional clinical interviews and supports responsible expansion of digital mental health access.

Read More »
02/11/2026
Mentavi Health Research Study, J Clin Psychiatry, photo credit: Daenin
Insights

Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care

Source: The Journal of Clinical Psychiatry
Mentavi Health, a Portfolio Company of Boomerang Ventures, is the lead author of a groundbreaking study published in the Journal of Clinical Psychiatry, “Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care.” The research validates the accuracy of Mentavi’s online ADHD assessment in a real-world sample of adults seeking web-based mental healthcare. Findings demonstrate strong diagnostic agreement with clinician-led interviews and highlight the tool’s high positive predictive value, providing a clinically reliable and scalable solution to expand access to ADHD evaluation.

Read More »
09/08/2025

Back to News Page

Boomerang Ventures
Loading...